Searchable abstracts of presentations at key conferences in endocrinology

ea0085p21 | Diabetes 1 | BSPED2022

Using language to empower joint diabetes decision making in the paediatric diabetes clinic

Ali Ashiya , Hurley Catriona , Giwa Sarah , Magennis Loraine

Introduction: Historically there are many examples of doctors using language which does not aid joint decision making with patients. At medical school we are taught to find out the presenting complaint rather than the reason for attendance. We write about non-compliance with treatment in the medical records rather than barriers to adherence. Similarly we use language in the Diabetes clinic which can disempower the children and families who attend our clinics.<p class="abst...

ea0025mte9 | (1) | SFEBES2011

microRNAs – key contributors to endocrinology

O'Driscoll Lorraine

MicroRNAs (miRNAs) are a family of endogenous small noncoding RNA molecules, of 19–28 nucleotides in length. In humans, up to 3% of all genes are estimated to encode these evolutionarily conserved sequences. miRNAs are thought to control expression of thousands of target mRNAs. Mammalian miRNAs generally negatively regulate gene expression by repressing translation, possibly through effects on mRNA stability and compartmentalisation, and/or the translation process itself....

ea0012p50 | Diabetes, metabolism and cardiovascular | SFE2006

Evidence for a safe switch from human premixed insulin to BIAsp 30 in twice-daily regimens – data from the REACH study

McNally PG , Page S , Compion G , Lorains J

AimsThe premixed insulin analogue, biphasic insulin aspart 30/70 (BIAsp 30, 30% insulin aspart, 70% protaminated aspart) has a more physiological absorption profile than conventional premixed insulin, biphasic human insulin 30/70 (BHI 30, 30% soluble human insulin, 70% NPH), but no studies have previously tested how a switch from BHI 30 to BIAsp 30 can be done safely using a simple guideline. We investigated the occurrence of low interstitial glucose (IG...

ea0034se1.5 | (1) | SFEBES2014

Steroid merchants of Edinburgh

Mason J Ian

We present a commentary based on both history and experiences of the many contributions to steroid biochemistry and endocrinology made in Edinburgh over the past 75 years. Reflections will be made commencing with the contributions of Guy Marrian (1904–1981) and colleagues. Marian, occupied the Chair of Medicine with relation to Medicine (later Medical Biochemistry, then Biochemistry) at Edinburgh University from 1939 until his appointment as Director of the ICRF Laborator...

ea0077p59 | Metabolism, Obesity and Diabetes | SFEBES2021

Acidosis reduces 11β-HSD1 activity in human primary muscle cell cultures

Sagmeister Michael , Nicholson Thomas , Harper Lorraine , Jones Simon , Hardy Rowan

Background: Acidosis activates the hypothalamic-pituitary-adrenal (HPA) axis and induces glucocorticoid-mediated atrophy of skeletal muscle. The enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) converts inactive cortisone to active cortisol and modulates glucocorticoid signalling locally within skeletal muscle. Here, we address a gap in knowledge how acidosis affects 11β-HSD1 activity in human skeletal muscle cells.Methods: Quadrice...

ea0086p59 | Metabolism, Obesity and Diabetes | SFEBES2022

The role of glucocorticoid activation by 11bHSD1 for muscle wasting in a mouse model of renal impairment

Sagmeister Michael , Crastin Ana , Jones Simon , Harper Lorraine , Hardy Rowan

Background: Chronic kidney disease aggravates loss of skeletal muscles mass and function, which is an independent risk factor for hospitalisation, morbidity and mortality. Glucocorticoid signalling has been implicated as a critical factor in the pathogenesis of muscle atrophy in kidney disease. This study tests whether genetic deletion of the glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11bHSD1) protects against muscle atrophy in the adenine-die...

ea0038fp6 | (1) | SFEBES2015

The role of 11β-hydroxysteroid dehydrogenase type 2 in the central regulation of blood pressure and salt appetite

McNairn Julie , Bailey Matthew , Moran Carmel , Work Lorraine , Holmes Megan

Increased intake of sodium is postulated to be controlled by aldosterone-sensitive cells in a select region of the adult mouse brain, the nucleus of the solitary tract (NTS). These cells express the enzyme 11β-hydroxysteroid dehydrogenase type 2 (HSD2) which inactivates glucocorticoids, allowing selective activation of mineralocorticoid receptors by aldosterone. However in the developing brain, HSD2 is widely expressed to protect against adverse glucocorticoid action, whi...

ea0021p10 | Bone | SFEBES2009

Recurrence of spontaneously resolving hypercalcaemia, an unusual case

Jaleel Nihad , Meeking Darryl , Albon Lorraine , Chong Lina

A 67-year male presented to his GP with polydypsia, ployuria and bone pains. Routine blood tests showed hypercalcemia (corrected calcium 2.77 mmol/l). Patient was otherwise well. He had a history of ethanol abuse, hypertension and gout.Medications: Allopurinol, ramipril simvastatin and co-dydramol. Repeat blood tests after 4 weeks show a rising calcium of 3.24 mmol/l with intact PTH 33.6 pmol/l (<6.4). He was referred to our endocrinology department ...

ea0094oc5.5 | Adrenal and Cardiovascular | SFEBES2023

Identification of micrornas targeting the mineralocorticoid receptor with therapeutic potential in vascular cognitive impairment

Birch Lara , Fullerton Josie , MacKenzie Scott , Work Lorraine , Davies Eleanor

Hypertension is the most important risk factor in the development of cerebrovascular diseases including vascular cognitive impairment (VCI). Aldosterone is a key regulator of blood pressure, acting via the mineralocorticoid receptor (MR) in the kidney to promote sodium/water reabsorption. Elevated aldosterone, as in primary aldosteronism (PA) is a risk factor for cerebrovascular disease. In addition to its traditional role, the MR is expressed throughout the brain and vasculat...

ea0075o07 | Obesity, metabolism &amp; miscellaneous endocrinology | EYES2021

Dietary patterns as risk factor for arterial stiffness and carotid atherosclerosis in menopause

Mili Nikoletta , Karagkouni Iliana , Delialis Dimitris , Yannakoulia Mary , Armeni Eleni , Papavangelis Christos , Augoulea Areti , Kouerinis Efthymios , Kontou Loraina , Paschou Stavroula , Mavraganis Georgios , Aravantinos Leon , Stamatelopoulos Kimon , Lambrinoudaki Irene

Background: Apart from traditional cardiovascular-risk factors and fluctuating sex hormone levels, environmental and lifestyle factors might also contribute to the heightened cardiovascular risk after menopause.Objective: To explore whether nutritional factors are associated with subclinical vessel disease in postmenopausal women.Methods: This cross-sectional study recruited 310 apparently healthy postmenopausal women, attending a ...